AXGN

Axogen (AXGN)

Axogen Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AXGN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/02	20:00	GlobeNewswire Inc.	Axogen, Inc Reports First Quarter 2024 Financial Results	NASDAQ:AXGN	Axogen Inc
2024/04/30	05:50	GlobeNewswire Inc.	Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™	NASDAQ:AXGN	Axogen Inc
2024/04/16	20:00	GlobeNewswire Inc.	Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	NASDAQ:AXGN	Axogen Inc
2024/03/09	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/03/09	07:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/03/09	06:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc
2024/03/08	08:12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
2024/03/08	06:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
2024/03/06	22:59	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AXGN	Axogen Inc
2024/03/06	22:53	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:AXGN	Axogen Inc
2024/03/06	22:45	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:AXGN	Axogen Inc
2024/03/06	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/03/06	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc
2024/03/05	21:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc
2024/03/05	21:00	GlobeNewswire Inc.	Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	NASDAQ:AXGN	Axogen Inc
2024/02/24	06:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/02/24	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/02/24	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/02/15	05:22	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AXGN	Axogen Inc
2024/02/14	06:30	GlobeNewswire Inc.	Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024	NASDAQ:AXGN	Axogen Inc
2024/02/13	03:21	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AXGN	Axogen Inc
2024/02/07	07:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXGN	Axogen Inc
2024/02/03	06:15	GlobeNewswire Inc.	Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:AXGN	Axogen Inc
2024/02/02	23:29	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AXGN	Axogen Inc
2024/01/27	01:49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AXGN	Axogen Inc
2024/01/19	07:00	GlobeNewswire Inc.	Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap	NASDAQ:AXGN	Axogen Inc
2024/01/12	07:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/01/12	07:10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/01/12	07:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AXGN	Axogen Inc
2024/01/08	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXGN	Axogen Inc